Gujarat Alkalies and Chemicals DuPont analysis

Per cent unless marked ×
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
0.46×−0.05×−6.70×1.21×0.48×
1.53×−4.74×−0.30×0.81×1.03×
2.1%−0.2%−0.8%−6.3%18.6%
0.56×0.56×0.51×0.47×0.55×
1.45×1.45×1.41×1.32×1.36×
1.2%−0.0%−1.1%−3.9%6.8%
−0.0%−0.0%−1.1%−3.9%6.8%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

GUJALKALI₹544.00

Gujarat Alkalies and Chemicals Limited

· Chemicals
₹ CrorePeersYASHOEPIGRALFOSECOINDFCLVISHNUTATVAGALAXYSURFJUBLCPLMcap ₹3,995 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×0.481.21-6.70-0.050.46
Interest Burden (Pretax/EBIT) ×1.030.81-0.30-4.741.53
EBIT Margin %18.57-6.34-0.78-0.212.10
Asset Turnover ×0.550.470.510.560.56
Financial Leverage (Assets/Equity) ×1.361.321.411.451.45
ROE (5-step product, year-end total equity) %6.77-3.86-1.15-0.041.20
ROE (owners' profit / average owners' equity) %6.81-3.88-1.11-0.04-0.04
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.